出産後の血小板α2-アドレノ受容体結合の変化:妊産婦のブルースとの可能性のある関係
Lancet (London, England)
|March 5, 1983
まとめ
血小板α2-アドレノ受容体 (a2AR) の産後変化が研究されました. 出産後のa2AR能力の遅れた低下は,女性の妊産婦のブルースに関連している可能性があります.
科学分野:
- 生殖内分泌学 生殖内分泌学
- 神経薬理学神経薬理学について
- 生後期の精神的健康については,
背景:
- 産前期間のホルモン変動は,生理学的プロセスに大きく影響します.
- 産後うつ病は,出産後の女性のかなりの割合に影響します.
- アドレノ受容体は,気分調節と生理学的反応に役割を果たします.
研究 の 目的:
- 周産期中の女性における血小板α2-アドレノ受容体結合特性を調査する.
- これらの受容体の変化と妊産婦のブルースの発達との関係を調査する.
- エストロゲンとプロゲステロンの血小板α2-アドレノ受容体への影響を評価するために,産後.
主な方法:
- 産前期間に28人の健康な女性を研究した.
- 測定された血小板α2-アドレノ受容体結合特性.
- 循環中のエストロゲンとプロゲステロンと相関する受容体レベル.
- 妊産婦のうつ病とうつ病のない女性の受容体容量,および対照群の受容体容量の比較.
主要な成果:
- 血小板α2-アドレノ受容体数は出産後に減少し,エストロゲンとプロゲステロンの低下と相関しています.
- 産後ブルースを経験した女性は,対照群と比較して,産後7〜10日後に血小板α2-アドレノ受容体容量が有意に高かった.
- この増加した容量は,産婦人ブルースのない女性よりも著しく高かった.
結論:
- 循環中の内生性エストロゲンとプロゲステロンのレベルは,血小板α2-アドレノ受容体に影響します.
- 血小板α2-アドレノ受容体能力の遅延または減少した産後の低下は,妊産婦のブルースと関連付けられます.
- 血小板α2-アドレノ受容体は,産後気分障害の潜在的なバイオマーカーとして機能する.
さらに関連する動画
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
05:31Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
関連する概念動画
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
